Changes in Brain Energy and Membrane Metabolism in Glioblastoma following Chemoradiation

Brain parenchyma infiltration with glioblastoma (GB) cannot be entirely visualized by conventional magnetic resonance imaging (MRI). The aim of this study was to investigate changes in the energy and membrane metabolism measured with phosphorous MR spectroscopy (31P-MRS) in the presumably “normal-ap...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current oncology (Toronto) Jg. 28; H. 6; S. 5041 - 5053
Hauptverfasser: Grams, Astrid Ellen, Mangesius, Stephanie, Steiger, Ruth, Radovic, Ivan, Rietzler, Andreas, Walchhofer, Lisa Maria, Galijašević, Malik, Mangesius, Julian, Nowosielski, Martha, Freyschlag, Christian Franz, Kerschbaumer, Johannes, Gizewski, Elke Ruth
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Switzerland MDPI 01.12.2021
MDPI AG
Schlagworte:
ISSN:1718-7729, 1198-0052, 1718-7729
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Brain parenchyma infiltration with glioblastoma (GB) cannot be entirely visualized by conventional magnetic resonance imaging (MRI). The aim of this study was to investigate changes in the energy and membrane metabolism measured with phosphorous MR spectroscopy (31P-MRS) in the presumably “normal-appearing” brain following chemoradiation therapy (CRT) in GB patients in comparison to healthy controls. Twenty (seven female, thirteen male) GB patients underwent a 31P-MRS scan prior to surgery (baseline) and after three months of standard CRT (follow-up examination. The regions of interest “contrast-enhancing (CE) tumor” (if present), “adjacent to the (former) tumor”, “ipsilateral distant” hemisphere, and “contralateral” hemisphere were compared, differentiating between patients with stable (SD) and progressive disease (PD). Metabolite ratios PCr/ATP, Pi/ATP, PCr/Pi, PME/PDE, PME/PCr, and PDE/ATP were investigated. In PD, energy and membrane metabolism in CE tumor areas have a tendency to “normalize” under therapy. In different “normal-appearing” brain areas of GB patients, the energy and membrane metabolism either “normalized” or were “disturbed”, in comparison to baseline or controls. Differences were also detected between patients with SD and PD. 31P-MRS might contribute as an additional imaging biomarker for outcome measurement, which remains to be investigated in a larger cohort.
AbstractList Brain parenchyma infiltration with glioblastoma (GB) cannot be entirely visualized by conventional magnetic resonance imaging (MRI). The aim of this study was to investigate changes in the energy and membrane metabolism measured with phosphorous MR spectroscopy (31P-MRS) in the presumably “normal-appearing” brain following chemoradiation therapy (CRT) in GB patients in comparison to healthy controls. Twenty (seven female, thirteen male) GB patients underwent a 31P-MRS scan prior to surgery (baseline) and after three months of standard CRT (follow-up examination. The regions of interest “contrast-enhancing (CE) tumor” (if present), “adjacent to the (former) tumor”, “ipsilateral distant” hemisphere, and “contralateral” hemisphere were compared, differentiating between patients with stable (SD) and progressive disease (PD). Metabolite ratios PCr/ATP, Pi/ATP, PCr/Pi, PME/PDE, PME/PCr, and PDE/ATP were investigated. In PD, energy and membrane metabolism in CE tumor areas have a tendency to “normalize” under therapy. In different “normal-appearing” brain areas of GB patients, the energy and membrane metabolism either “normalized” or were “disturbed”, in comparison to baseline or controls. Differences were also detected between patients with SD and PD. 31P-MRS might contribute as an additional imaging biomarker for outcome measurement, which remains to be investigated in a larger cohort.
Brain parenchyma infiltration with glioblastoma (GB) cannot be entirely visualized by conventional magnetic resonance imaging (MRI). The aim of this study was to investigate changes in the energy and membrane metabolism measured with phosphorous MR spectroscopy (31P-MRS) in the presumably "normal-appearing" brain following chemoradiation therapy (CRT) in GB patients in comparison to healthy controls. Twenty (seven female, thirteen male) GB patients underwent a 31P-MRS scan prior to surgery (baseline) and after three months of standard CRT (follow-up examination. The regions of interest "contrast-enhancing (CE) tumor" (if present), "adjacent to the (former) tumor", "ipsilateral distant" hemisphere, and "contralateral" hemisphere were compared, differentiating between patients with stable (SD) and progressive disease (PD). Metabolite ratios PCr/ATP, Pi/ATP, PCr/Pi, PME/PDE, PME/PCr, and PDE/ATP were investigated. In PD, energy and membrane metabolism in CE tumor areas have a tendency to "normalize" under therapy. In different "normal-appearing" brain areas of GB patients, the energy and membrane metabolism either "normalized" or were "disturbed", in comparison to baseline or controls. Differences were also detected between patients with SD and PD. 31P-MRS might contribute as an additional imaging biomarker for outcome measurement, which remains to be investigated in a larger cohort.Brain parenchyma infiltration with glioblastoma (GB) cannot be entirely visualized by conventional magnetic resonance imaging (MRI). The aim of this study was to investigate changes in the energy and membrane metabolism measured with phosphorous MR spectroscopy (31P-MRS) in the presumably "normal-appearing" brain following chemoradiation therapy (CRT) in GB patients in comparison to healthy controls. Twenty (seven female, thirteen male) GB patients underwent a 31P-MRS scan prior to surgery (baseline) and after three months of standard CRT (follow-up examination. The regions of interest "contrast-enhancing (CE) tumor" (if present), "adjacent to the (former) tumor", "ipsilateral distant" hemisphere, and "contralateral" hemisphere were compared, differentiating between patients with stable (SD) and progressive disease (PD). Metabolite ratios PCr/ATP, Pi/ATP, PCr/Pi, PME/PDE, PME/PCr, and PDE/ATP were investigated. In PD, energy and membrane metabolism in CE tumor areas have a tendency to "normalize" under therapy. In different "normal-appearing" brain areas of GB patients, the energy and membrane metabolism either "normalized" or were "disturbed", in comparison to baseline or controls. Differences were also detected between patients with SD and PD. 31P-MRS might contribute as an additional imaging biomarker for outcome measurement, which remains to be investigated in a larger cohort.
Author Steiger, Ruth
Grams, Astrid Ellen
Radovic, Ivan
Mangesius, Julian
Nowosielski, Martha
Gizewski, Elke Ruth
Galijašević, Malik
Rietzler, Andreas
Freyschlag, Christian Franz
Kerschbaumer, Johannes
Mangesius, Stephanie
Walchhofer, Lisa Maria
AuthorAffiliation 1 Department of Neuroradiology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; astrid.grams@i-med.ac.at (A.E.G.); stephanie.mangeisus@i-med.ac.at (S.M.); ivan.radovic@icloud.com (I.R.); andreas.rietzler@i-med.ac.at (A.R.); malik.galijasevic@i-med.ac.at (M.G.); elke.gizewski@i-med.ac.at (E.R.G.)
4 Department of Radiation Oncology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; julian.mangesius@i-med.ac.at
2 Neuroimaging Core Facility, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria
6 Department of Neurosurgery, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; christian.freyschlag@i-med.ac.at (C.F.F.); johannes.kerschbaumer@i-med.ac.at (J.K.)
5 Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; martha.nowosielski@i-med.ac.at
3 Department of Radiology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; lisa.walchhof
AuthorAffiliation_xml – name: 3 Department of Radiology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; lisa.walchhofer@kh-schwaz.at
– name: 6 Department of Neurosurgery, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; christian.freyschlag@i-med.ac.at (C.F.F.); johannes.kerschbaumer@i-med.ac.at (J.K.)
– name: 2 Neuroimaging Core Facility, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria
– name: 1 Department of Neuroradiology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; astrid.grams@i-med.ac.at (A.E.G.); stephanie.mangeisus@i-med.ac.at (S.M.); ivan.radovic@icloud.com (I.R.); andreas.rietzler@i-med.ac.at (A.R.); malik.galijasevic@i-med.ac.at (M.G.); elke.gizewski@i-med.ac.at (E.R.G.)
– name: 4 Department of Radiation Oncology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; julian.mangesius@i-med.ac.at
– name: 5 Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; martha.nowosielski@i-med.ac.at
Author_xml – sequence: 1
  givenname: Astrid Ellen
  orcidid: 0000-0003-2304-3946
  surname: Grams
  fullname: Grams, Astrid Ellen
– sequence: 2
  givenname: Stephanie
  orcidid: 0000-0001-5790-2724
  surname: Mangesius
  fullname: Mangesius, Stephanie
– sequence: 3
  givenname: Ruth
  surname: Steiger
  fullname: Steiger, Ruth
– sequence: 4
  givenname: Ivan
  surname: Radovic
  fullname: Radovic, Ivan
– sequence: 5
  givenname: Andreas
  orcidid: 0000-0002-0808-2667
  surname: Rietzler
  fullname: Rietzler, Andreas
– sequence: 6
  givenname: Lisa Maria
  surname: Walchhofer
  fullname: Walchhofer, Lisa Maria
– sequence: 7
  givenname: Malik
  orcidid: 0000-0001-6577-0784
  surname: Galijašević
  fullname: Galijašević, Malik
– sequence: 8
  givenname: Julian
  orcidid: 0000-0003-0855-1870
  surname: Mangesius
  fullname: Mangesius, Julian
– sequence: 9
  givenname: Martha
  orcidid: 0000-0002-8068-315X
  surname: Nowosielski
  fullname: Nowosielski, Martha
– sequence: 10
  givenname: Christian Franz
  orcidid: 0000-0002-8228-8217
  surname: Freyschlag
  fullname: Freyschlag, Christian Franz
– sequence: 11
  givenname: Johannes
  surname: Kerschbaumer
  fullname: Kerschbaumer, Johannes
– sequence: 12
  givenname: Elke Ruth
  surname: Gizewski
  fullname: Gizewski, Elke Ruth
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34940063$$D View this record in MEDLINE/PubMed
BookMark eNp1kk1v1DAQhi1URD9_ABeUI5eFsZ3EzgUJVm2pVMQFJG7W-CNZV45d7Cyo_75ut0UtiIs9M37fZ6TxHJK9mKIj5DWFd5wP8N5sc07RpMAk9NCy9gU5oILKlRBs2HsS75PDUq4AOBdCvCL7vB1agJ4fkB_rDcbJlcbH5lPGep5Gl6ebBqNtvrhZZ4yuBgvqFHyZ73TnwScdsCxpxmZMIaTfPk7NeuPmlNF6XHyKx-TliKG4k4f7iHw_O_22_ry6_Hp-sf54uTJt3y2rkRmgo5UUGR0MtLzlaEccLQ6Gg-xQ1FRrhswZYBR6lP0opOQdGtuB5UfkYse1Ca_UdfYz5huV0Kv7QsqTwrx4E5wCiZpL243WmbbjWrJOSyGHWqUIGirrw451vdWzs8bFJWN4Bn3-Ev1GTemXkgLq-PsKePsAyOnn1pVFzb4YF0IdYtoWxXrK2cCoYFX65mmvP00ev6YKxE5gciolu1EZv9yPtrb2QVFQd0ug_lmC6qR_OR_h__fcAhpPufw
CitedBy_id crossref_primary_10_3390_cancers17010124
crossref_primary_10_3390_cancers14246264
crossref_primary_10_1016_j_neurad_2021_11_006
crossref_primary_10_1007_s40336_022_00502_y
crossref_primary_10_25259_SNI_498_2024
crossref_primary_10_1002_jmri_29326
crossref_primary_10_3390_diagnostics14080841
crossref_primary_10_3390_biomedicines11020364
crossref_primary_10_3390_cancers14133197
Cites_doi 10.1016/j.clineuro.2012.01.026
10.1016/j.neuroimage.2005.12.052
10.1002/jmri.25619
10.3348/kjr.2013.14.3.477
10.1002/nbm.1940050506
10.2174/1570159X14666160121115641
10.1038/jcbfm.1987.106
10.1016/S0167-8140(02)00078-6
10.1016/0014-4827(82)90063-5
10.1212/WNL.39.4.538
10.1002/nbm.735
10.1016/S0735-1097(02)02160-5
10.1200/JCO.2009.26.3541
10.1007/s00062-017-0630-8
10.3390/cancers13143569
10.1007/s10334-008-0148-9
10.1016/j.molcel.2013.01.018
10.1371/journal.pone.0056439
10.1158/1538-7445.AM2020-4803
10.1002/nbm.891
10.3390/cancers13112598
10.1002/nbm.1621
10.1006/jmre.1997.1244
10.1093/brain/awp293
10.1215/S1152851703000620
10.1056/NEJMoa043330
10.1159/000017471
10.1227/00006123-199604000-00026
10.1016/S0021-9258(18)48107-0
10.3174/ajnr.A3702
10.1001/archneurol.2011.2910
10.1111/bdi.12339
10.1038/nrn3765
10.1016/j.ejrad.2013.11.009
10.1002/nbm.1109
10.1002/mrm.20312
10.1177/197140090702000608
10.1093/neuonc/nor132
10.1002/jmri.25278
ContentType Journal Article
Copyright 2021 by the authors. 2021
Copyright_xml – notice: 2021 by the authors. 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.3390/curroncol28060424
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList CrossRef


MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1718-7729
EndPage 5053
ExternalDocumentID oai_doaj_org_article_08ab38d5fdec453b825b8789ab31a0b0
PMC8700426
34940063
10_3390_curroncol28060424
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Oesterreichische Nationalbank
  grantid: 15866
GroupedDBID ---
04C
29F
2WC
53G
5GY
5VS
6PF
AAWTL
AAYXX
ABDBF
ACGFS
ACUHS
ADBBV
AENEX
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BMSDO
CITATION
CS3
DIK
DU5
E3Z
EBD
EBS
EIHBH
EJD
ESX
F5P
GROUPED_DOAJ
HYE
KQ8
MODMG
OK1
OVT
RNS
RPM
TR2
TUS
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c465t-f2c01fd81a219c04343adfafda9c3085a7adfbb2a2ec02106a86f78835acd50d3
IEDL.DBID DOA
ISICitedReferencesCount 9
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000736647100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1718-7729
1198-0052
IngestDate Fri Oct 03 12:29:30 EDT 2025
Thu Aug 21 14:14:37 EDT 2025
Thu Jul 10 18:09:20 EDT 2025
Thu Apr 03 07:09:13 EDT 2025
Tue Nov 18 21:06:59 EST 2025
Thu Oct 16 04:40:13 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords glioblastoma
normal-appearing brain tissue
tumor infiltration
cerebral energy metabolism
ATP
chemoradiation
phosphorous magnetic resonance spectroscopy (31P-MRS)
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c465t-f2c01fd81a219c04343adfafda9c3085a7adfbb2a2ec02106a86f78835acd50d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Contributed equally, shared first author.
ORCID 0000-0001-6577-0784
0000-0001-5790-2724
0000-0003-0855-1870
0000-0002-0808-2667
0000-0002-8228-8217
0000-0002-8068-315X
0000-0003-2304-3946
OpenAccessLink https://doaj.org/article/08ab38d5fdec453b825b8789ab31a0b0
PMID 34940063
PQID 2613292172
PQPubID 23479
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_08ab38d5fdec453b825b8789ab31a0b0
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8700426
proquest_miscellaneous_2613292172
pubmed_primary_34940063
crossref_citationtrail_10_3390_curroncol28060424
crossref_primary_10_3390_curroncol28060424
PublicationCentury 2000
PublicationDate 2021-12-01
20211201
PublicationDateYYYYMMDD 2021-12-01
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-01
  day: 01
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Current oncology (Toronto)
PublicationTitleAlternate Curr Oncol
PublicationYear 2021
Publisher MDPI
MDPI AG
Publisher_xml – name: MDPI
– name: MDPI AG
References Stupp (ref_1) 2005; 352
Metallo (ref_41) 2013; 49
Hattingen (ref_35) 2009; 22
Novak (ref_29) 2014; 83
Sahm (ref_5) 2012; 69
Guntuku (ref_44) 2016; 14
Maintz (ref_21) 2002; 15
Wen (ref_33) 2010; 28
Hattingen (ref_37) 2009; 132
Kemp (ref_14) 2000; 22
Hattingen (ref_36) 2011; 24
Daly (ref_16) 1987; 262
Laperriere (ref_31) 2002; 64
Lin (ref_12) 2016; 44
Ha (ref_19) 2013; 14
Vanhamme (ref_39) 1997; 129
Steiger (ref_34) 2018; 2018
Stark (ref_32) 2012; 114
Lamborn (ref_30) 2004; 6
Albers (ref_15) 2005; 53
Kamble (ref_23) 2014; 8
Hattingen (ref_26) 2011; 13
Lenz (ref_43) 2020; 80
Vink (ref_10) 1987; 7
Scherer (ref_4) 1938; 34
Skog (ref_42) 1982; 141
Stieltjes (ref_8) 2006; 31
Inglese (ref_6) 2006; 27
Sternberg (ref_7) 2014; 35
Welch (ref_13) 1989; 39
ref_20
Wenger (ref_38) 2019; 29
Kreis (ref_40) 2004; 17
Beer (ref_9) 2002; 40
Hnilicova (ref_25) 2020; 121
ref_28
Cohen (ref_17) 1992; 5
Shi (ref_18) 2015; 17
Wenger (ref_24) 2017; 46
ref_27
Chance (ref_11) 2006; 19
Bulakbasi (ref_22) 2007; 20
Giese (ref_2) 1996; 38
Cuddapah (ref_3) 2014; 15
References_xml – volume: 114
  start-page: 840
  year: 2012
  ident: ref_32
  article-title: Glioblastoma: Clinical characteristics, prognostic factors and survival in 492 patients
  publication-title: Clin. Neurol. Neurosurg.
  doi: 10.1016/j.clineuro.2012.01.026
– volume: 31
  start-page: 531
  year: 2006
  ident: ref_8
  article-title: Diffusion tensor imaging in primary brain tumors: Reproducible quantitative analysis of corpus callosum infiltration and contralateral involvement using a probabilistic mixture model
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2005.12.052
– volume: 46
  start-page: 1200
  year: 2017
  ident: ref_24
  article-title: Intracellular pH measured by (31) P-MR-spectroscopy might predict site of progression in recurrent glioblastoma under antiangiogenic therapy
  publication-title: J. Magn. Reson. Imaging JMRI
  doi: 10.1002/jmri.25619
– volume: 121
  start-page: 488
  year: 2020
  ident: ref_25
  article-title: Noninvasive study of brain tumours metabolism using phosphorus-31 magnetic resonance spectroscopy
  publication-title: Bratisl. Lek. Listy
– volume: 14
  start-page: 477
  year: 2013
  ident: ref_19
  article-title: Application of 31P MR spectroscopy to the brain tumors
  publication-title: Korean J. Radiol.
  doi: 10.3348/kjr.2013.14.3.477
– volume: 5
  start-page: 226
  year: 1992
  ident: ref_17
  article-title: Phospholipid metabolites as indicators of cancer cell function
  publication-title: NMR Biomed.
  doi: 10.1002/nbm.1940050506
– volume: 14
  start-page: 567
  year: 2016
  ident: ref_44
  article-title: Mitochondrial Dysfunction in Gliomas: Pharmacotherapeutic Potential of Natural Compounds
  publication-title: Curr. Neuropharmacol.
  doi: 10.2174/1570159X14666160121115641
– volume: 34
  start-page: 333
  year: 1938
  ident: ref_4
  article-title: Structural development in gliomas
  publication-title: Am. J. Cancer
– volume: 7
  start-page: 563
  year: 1987
  ident: ref_10
  article-title: Effects of traumatic brain injury on cerebral high-energy phosphates and pH: A 31P magnetic resonance spectroscopy study
  publication-title: J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab.
  doi: 10.1038/jcbfm.1987.106
– volume: 64
  start-page: 259
  year: 2002
  ident: ref_31
  article-title: Radiotherapy for newly diagnosed malignant glioma in adults: A systematic review
  publication-title: Radiother. Oncol.
  doi: 10.1016/S0167-8140(02)00078-6
– volume: 141
  start-page: 23
  year: 1982
  ident: ref_42
  article-title: Energy metabolism and ATP turnover time during the cell cycle of Ehrlich ascites tumour cells
  publication-title: Exp. Cell Res.
  doi: 10.1016/0014-4827(82)90063-5
– volume: 2018
  start-page: 7806395
  year: 2018
  ident: ref_34
  article-title: Cerebral Phosphorus Magnetic Resonance Spectroscopy in a Patient with Giant Cell Arteritis and Endovascular Therapy
  publication-title: Case Rep. Radiol.
– volume: 39
  start-page: 538
  year: 1989
  ident: ref_13
  article-title: Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy
  publication-title: Neurology
  doi: 10.1212/WNL.39.4.538
– volume: 15
  start-page: 18
  year: 2002
  ident: ref_21
  article-title: Phosphorus-31 MR spectroscopy of normal adult human brain and brain tumours
  publication-title: NMR Biomed.
  doi: 10.1002/nbm.735
– volume: 40
  start-page: 1267
  year: 2002
  ident: ref_9
  article-title: Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/S0735-1097(02)02160-5
– volume: 8
  start-page: Rc05
  year: 2014
  ident: ref_23
  article-title: Energy status and metabolism in intracranial space occupying lesions: A prospective 31p spectroscopic study
  publication-title: J. Clin. Diagn. Res.
– volume: 28
  start-page: 1963
  year: 2010
  ident: ref_33
  article-title: Updated response assessment criteria for high-grade gliomas: Response assessment in neuro-oncology working group
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2009.26.3541
– volume: 29
  start-page: 27
  year: 2019
  ident: ref_38
  article-title: In vivo Metabolic Profiles as Determined by (31)P and short TE (1)H MR-Spectroscopy: No Difference Between Patients with IDH Wildtype and IDH Mutant Gliomas
  publication-title: Clin. Neuroradiol.
  doi: 10.1007/s00062-017-0630-8
– ident: ref_28
  doi: 10.3390/cancers13143569
– volume: 22
  start-page: 43
  year: 2009
  ident: ref_35
  article-title: Combined 1H and 31P MR spectroscopic imaging: Impaired energy metabolism in severe carotid stenosis and changes upon treatment
  publication-title: MAGMA
  doi: 10.1007/s10334-008-0148-9
– volume: 49
  start-page: 388
  year: 2013
  ident: ref_41
  article-title: Understanding metabolic regulation and its influence on cell physiology
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2013.01.018
– ident: ref_20
  doi: 10.1371/journal.pone.0056439
– volume: 80
  start-page: 4803
  year: 2020
  ident: ref_43
  article-title: Mitochondrial response to temozolomide treatment in glioma cells
  publication-title: Cancer Res.
  doi: 10.1158/1538-7445.AM2020-4803
– volume: 17
  start-page: 361
  year: 2004
  ident: ref_40
  article-title: Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts
  publication-title: NMR Biomed.
  doi: 10.1002/nbm.891
– ident: ref_27
  doi: 10.3390/cancers13112598
– volume: 24
  start-page: 536
  year: 2011
  ident: ref_36
  article-title: Combined (1)H and (31)P spectroscopy provides new insights into the pathobiochemistry of brain damage in multiple sclerosis
  publication-title: NMR Biomed.
  doi: 10.1002/nbm.1621
– volume: 129
  start-page: 35
  year: 1997
  ident: ref_39
  article-title: Improved method for accurate and efficient quantification of MRS data with use of prior knowledge
  publication-title: J. Magn. Reson.
  doi: 10.1006/jmre.1997.1244
– volume: 132
  start-page: 3285
  year: 2009
  ident: ref_37
  article-title: Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson’s disease
  publication-title: Brain A J. Neurol.
  doi: 10.1093/brain/awp293
– volume: 6
  start-page: 227
  year: 2004
  ident: ref_30
  article-title: Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysis
  publication-title: Neuro. Oncol.
  doi: 10.1215/S1152851703000620
– volume: 352
  start-page: 987
  year: 2005
  ident: ref_1
  article-title: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa043330
– volume: 27
  start-page: 2137
  year: 2006
  ident: ref_6
  article-title: Whole-brain N-acetylaspartate spectroscopy and diffusion tensor imaging in patients with newly diagnosed gliomas: A preliminary study
  publication-title: AJNR Am. J. Neuroradiol.
– volume: 22
  start-page: 418
  year: 2000
  ident: ref_14
  article-title: Non-invasive methods for studying brain energy metabolism: What they show and what it means
  publication-title: Dev. Neurosci.
  doi: 10.1159/000017471
– volume: 38
  start-page: 755
  year: 1996
  ident: ref_2
  article-title: Migration of human glioma cells on myelin
  publication-title: Neurosurgery
  doi: 10.1227/00006123-199604000-00026
– volume: 262
  start-page: 14875
  year: 1987
  ident: ref_16
  article-title: Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)48107-0
– volume: 35
  start-page: 439
  year: 2014
  ident: ref_7
  article-title: Utility of diffusion tensor imaging in evaluation of the peritumoral region in patients with primary and metastatic brain tumors
  publication-title: AJNR Am. J. Neuroradiol.
  doi: 10.3174/ajnr.A3702
– volume: 69
  start-page: 523
  year: 2012
  ident: ref_5
  article-title: Addressing diffuse glioma as a systemic brain disease with single-cell analysis
  publication-title: Arch. Neurol.
  doi: 10.1001/archneurol.2011.2910
– volume: 17
  start-page: 743
  year: 2015
  ident: ref_18
  article-title: Decreased brain PME/PDE ratio in bipolar disorder: A preliminary (31) P magnetic resonance spectroscopy study
  publication-title: Bipolar Disord.
  doi: 10.1111/bdi.12339
– volume: 15
  start-page: 455
  year: 2014
  ident: ref_3
  article-title: A neurocentric perspective on glioma invasion
  publication-title: Nat. Rev. Neurosci.
  doi: 10.1038/nrn3765
– volume: 83
  start-page: e106
  year: 2014
  ident: ref_29
  article-title: Clinical protocols for (3)(1)P MRS of the brain and their use in evaluating optic pathway gliomas in children
  publication-title: Eur. J. Radiol.
  doi: 10.1016/j.ejrad.2013.11.009
– volume: 19
  start-page: 904
  year: 2006
  ident: ref_11
  article-title: Skeletal muscle energetics with PNMR: Personal views and historic perspectives
  publication-title: NMR Biomed.
  doi: 10.1002/nbm.1109
– volume: 53
  start-page: 22
  year: 2005
  ident: ref_15
  article-title: Proton-decoupled 31P MRS in untreated pediatric brain tumors
  publication-title: Magn. Reson. Med.
  doi: 10.1002/mrm.20312
– volume: 20
  start-page: 646
  year: 2007
  ident: ref_22
  article-title: Efficacy of in vivo 31Phosphorus Magnetic Resonance Spectroscopy in Differentiation and Staging of Adult Human Brain Tumors
  publication-title: Neuroradiol. J.
  doi: 10.1177/197140090702000608
– volume: 13
  start-page: 1349
  year: 2011
  ident: ref_26
  article-title: Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: A 31P/1H MRSI and quantitative magnetic resonance imaging study
  publication-title: Neuro-Oncology
  doi: 10.1093/neuonc/nor132
– volume: 44
  start-page: 1132
  year: 2016
  ident: ref_12
  article-title: MRI assessment of regional differences in phosphorus-31 metabolism and morphological abnormalities of the foot muscles in diabetes
  publication-title: J. Magn. Reson. Imaging JMRI
  doi: 10.1002/jmri.25278
SSID ssj0033777
Score 2.3051813
Snippet Brain parenchyma infiltration with glioblastoma (GB) cannot be entirely visualized by conventional magnetic resonance imaging (MRI). The aim of this study was...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 5041
SubjectTerms ATP
Brain
cerebral energy metabolism
chemoradiation
Chemoradiotherapy
Female
glioblastoma
Glioblastoma - diagnostic imaging
Glioblastoma - metabolism
Glioblastoma - therapy
Humans
Magnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Male
normal-appearing brain tissue
phosphorous magnetic resonance spectroscopy (31P-MRS)
Title Changes in Brain Energy and Membrane Metabolism in Glioblastoma following Chemoradiation
URI https://www.ncbi.nlm.nih.gov/pubmed/34940063
https://www.proquest.com/docview/2613292172
https://pubmed.ncbi.nlm.nih.gov/PMC8700426
https://doaj.org/article/08ab38d5fdec453b825b8789ab31a0b0
Volume 28
WOSCitedRecordID wos000736647100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1718-7729
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0033777
  issn: 1718-7729
  databaseCode: DOA
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9QwDLZghRAXxJvyWBWJE1K1adM06ZFFu3BgVxwAza3KU1SaaVczHfj72ElntAMILtzaNFEj20n8yfFngNfa-VBb1RSVMFVRKxcK5UtXBN5YbnQwTcx6__pRXl6qxaL9dK3UF90JS_TASXAnTGnDlRPBeVsLbhDRGCVVi62lZiaidSbbHZhKezDnUqayKpRAxkSV4pkcAf6J3a7X44BSppgiBf4OTqRI3P8nb_PXS5PXTqHze3B3dh_zt2na9-GGHx7A7Ys5QP4QFilbYJP3Q35K1R_ys5jcl-vB5Rd-hdh48Pgwoe6X_WZF_d4v-9GgEz2NK50HtIvxB55nOVEJoH24pLtH8OX87PO7D8VcPKGwdSOmIlSWlcGpUuOeZBklkGoXdHC6tRz9LC3x1ZhKV94S7mu0agLiYS60dYI5_hiOhnHwTyHHbozCfaVtRa0D0RlKg0Nb0TqNDkUGbCfAzs7M4lTgYtkhwiCZd7_JPIM3-yFXiVbjb51PSSv7jsSIHRvQTrrZTrp_2UkGr3Y67XAFUVgEBT5uNx1iSF61VKgrgydJx_tfEXkPeXEZyAPtH8zl8MvQf4ss3UpGfPrsf0z-Odyp6C5NvEbzAo6m9da_hFv2-9Rv1sdwUy7UcVwAPwHmbg0l
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Changes+in+Brain+Energy+and+Membrane+Metabolism+in+Glioblastoma+following+Chemoradiation&rft.jtitle=Current+oncology+%28Toronto%29&rft.au=Astrid+Ellen+Grams&rft.au=Stephanie+Mangesius&rft.au=Ruth+Steiger&rft.au=Ivan+Radovic&rft.date=2021-12-01&rft.pub=MDPI+AG&rft.issn=1198-0052&rft.eissn=1718-7729&rft.volume=28&rft.issue=6&rft.spage=5041&rft.epage=5053&rft_id=info:doi/10.3390%2Fcurroncol28060424&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_08ab38d5fdec453b825b8789ab31a0b0
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1718-7729&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1718-7729&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1718-7729&client=summon